Efficacy of CS-758, a Novel Triazole, against Experimental Fluconazole-Resistant Oropharyngeal Candidiasis in Mice

The therapeutic efficacy of CS-758, a novel triazole, was evaluated against experimental murine oropharyngeal candidiasis induced by Candida albicans with various susceptibilities to fluconazole. Against infections induced by strains with various susceptibilities to fluconazole, the efficacy of fluc...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	Antimicrob Agents Chemother
Principais autores:	Kamai, Yasuki, Kubota, Mikie, Fukuoka, Takashi, Kamai, Yoko, Maeda, Naoyuki, Hosokawa, Tsunemichi, Shibayama, Takahiro, Uchida, Katsuhisa, Yamaguchi, Hideyo, Kuwahara, Shogo
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Microbiology (ASM) 2003
נושאים:	Experimental Therapeutics
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC151753/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12543666/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.2.601-606.2003
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!